Neuroren

Neuroren has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €579,049 and a net result of €197,321. Equity is growing by about 22% per year across the filed financial years. Its solvency ranks better than 77% of 3,009 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).